-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
Mapping the breast cancer metastatic cascade onto circulating tumour DNA using genetic and epigenetic clonal tracking
Study
EGAS00001004014
-
Effect_of_FAM50_knockout_on_the_transcriptome
Study
EGAS00001004836
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___BD___WGS
Study
EGAS00001003014
-
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Study
EGAS00001004888
-
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Study
EGAS00001004030
-
RNA-seq data from Non Small Cell Lung Cancer (NSCLC) samples
Study
EGAS00001004032
-
Tumor HTG EdgeSeq from metastatic castrate resistant prostate cancer
Study
EGAS00001004852
-
Single_cell_ATAC_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008279
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Somatic_mutation_and_clonal_evolution_in_the_human_testes___WES
Study
EGAS00001003023
-
Oesophageal_Adenocarcinoma_Organoids_Iso_Seq
Study
EGAS00001004051
-
Heterogeneous metabolic signatures are linked to cancer cell differentiation in colorectal cancer
Study
EGAS00001004064
-
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary with Neuroendocrine Differentiation
Study
EGAS00001003026
-
Genomic and transcriptomic landscape of aggressive thyroid cancer
Study
EGAS00001003540
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Study
EGAS00001005549
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Whole exome sequencing data of germline and two independent primary leukemias of five patients
Study
EGAS00001001889
-
Whole exome sequencing on Pediatric MDS patients
Study
EGAS00001005432
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
Comprehensive pharmacogenomic characterization of gastric cancer
Study
EGAS00001004106
-
Human genomic and phenotypic synthetic data for the study of rare diseases
Study
EGAS00001005702
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___GI___TPS___WGS
Study
EGAS00001003089
-
Combination_Immune_Checkpoint_Inhibition_in_Australian_Rare_Cancers_WES
Study
EGAS00001005709
-
MicroRNA profiling by next-generation sequencing for colorectal cancer screening
Study
EGAS00001005030
-
DERMATLAS__Hidradenoma_papilliferum_RNAseq
Study
EGAS00001005715
-
Somatic mutations in endometriosis and normal uterine endometrium
Study
EGAS00001003095
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___GI___MAP___WGS
Study
EGAS00001004122
-
DERMATLAS__Porocarcinoma_RNAseq
Study
EGAS00001005721
-
Cancer immune control needs senescence induction by Stat1 dependent cell cycle regulator pathways in tumours
Study
EGAS00001004151
-
FAM50A_Disruption_in_TOV21G_Cells___RNAseq
Study
EGAS00001004156
-
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
Study
EGAS00001005055
-
Molecular_risk_stratification_in_patients_with_T1_colorectal_cancer_WES
Study
EGAS00001005734
-
Automated image-based profiling of complex drug induced phenotypes in patient-derived organoids
Study
EGAS00001003140
-
Panbody_nanoseq
Study
EGAS00001005521
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
Subtype specific studies of breast cancer progression. Milan cohort.
Study
EGAS00001004390
-
Targeted sequencing data of breast tumors with germline BRCA1/2 mutations
Dataset
EGAD00001005802
-
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer (CIN3+)
Study
EGAS00001005078
-
Detection of Cancer Mutations by Urine Liquid Biopsy in Bladder Cancer Patients
Study
EGAS00001005758
-
CRISPR transduction of iPS cells
Study
EGAS00001005102
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Single_cell_resolution_of_human_CNV_body_map
Study
EGAS00001003162
-
Persistence of circulating tumor DNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumor response
Study
EGAS00001005798
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_cytoscan)
Study
EGAS00001005584
-
A living biobank of breast cancer organoids captures disease heterogeneity
Study
EGAS00001002158
-
Somatic_mutation_in_skin_epidermis__SMS_
Study
EGAS00001002165
-
Genetics and therapeutic responses to TIL therapy of pancreatic cancer PDX models
Study
EGAS00001005596
-
COIN CRC GWAS data
Study
EGAS00001005421
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
Chemotherapy accelerates genomic aging of normal blood in children treated for cancer
Study
EGAS00001005141
-
Molecular origins of mpMRI visibility
Study
EGAS00001003179
-
TSG_knock_out_in_hiPSCs
Study
EGAS00001002262
-
Targeted sequencing of paired tumour/blood of 34 T1 stage bladder cancer patients
Study
EGAS00001005767
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001005230
-
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
Study
EGAS00001005769
-
Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing
Study
EGAS00001004289
-
MethCORR: DNA Methylation-based Characterization, Classification and Prognostication of Colorectal Cancer using Archival Formalin-fixed, Paraffin-embedded Tissue
Study
EGAS00001004293
-
The Landscape of Genetic Alterations in Hepatocellular Carcinoma, 88 matched HCC tumour/normal pairs WGS belongs to ICGC LICA-CN project
Study
EGAS00001002218
-
Rare occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
Study
EGAS00001005909
-
Hereditary Cancer Diagnostics with I2HCP gene panel
Study
EGAS00001004316
-
WGS_of_AML_during_PARPi_therapy
Study
EGAS00001002274
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
Nanopore_and_Illumina_sequencing_of_human_glioblastomas
Study
EGAS00001005812
-
Oesophageal_Adenocarcinoma_Organoid_10x
Study
EGAS00001003191
-
Comprehensive molecular characterization of brainstem glioma
Study
EGAS00001004341
-
DNA sequencing for human normal endometrial glands
Study
EGAS00001005822
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
Target gene sequencing for human normal endometrial glands
Study
EGAS00001005914
-
Genomic determination for Homologous Recombination Deficiency (HRD) by shallow Whole Genome Sequencing (sWGS)
Study
EGAS00001005926
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Cylindromas_sun_protected_and_exposed
Study
EGAS00001002521
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
Study
EGAS00001002604
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
The evolution of hematopoietic cells under cancer therapy
Study
EGAS00001005234
-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Study
EGAS00001005235
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
TP53 variant detection analysis in high grade serous epithelial ovarian cancer
Study
EGAS00001004361
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Study
EGAS00001005963
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Epigenetic analyses of methylation and nucleosome occupancy in cell-free DNA (cfNOMe)
Study
EGAS00001004370
-
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Study
EGAS00001004373
-
Temporal stability of circulating microRNAs in human serum
Study
EGAS00001003221
-
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Study
EGAS00001005984
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
Study
EGAS00001005952
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (RNA-seq)
Study
EGAS00001006016